| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.16B | 32.49B | 30.73B | 34.71B | 41.51B | 36.48B |
| Gross Profit | 4.77B | 3.88B | 4.10B | 7.82B | 12.50B | 11.03B |
| EBITDA | 4.91B | 4.11B | 4.49B | 7.69B | 11.57B | 10.23B |
| Net Income | 2.33B | 1.74B | 2.03B | 4.52B | 7.61B | 6.83B |
Balance Sheet | ||||||
| Total Assets | 35.63B | 35.10B | 33.94B | 35.34B | 32.48B | 25.82B |
| Cash, Cash Equivalents and Short-Term Investments | 2.48B | 2.70B | 4.14B | 7.13B | 4.86B | 2.62B |
| Total Debt | 7.12B | 7.12B | 6.95B | 6.84B | 6.69B | 5.68B |
| Total Liabilities | 13.09B | 12.98B | 12.52B | 13.22B | 12.91B | 11.22B |
| Stockholders Equity | 21.45B | 20.94B | 20.29B | 20.94B | 18.41B | 14.02B |
Cash Flow | ||||||
| Free Cash Flow | 532.00M | -188.00M | 806.00M | 4.90B | 8.12B | 4.61B |
| Operating Cash Flow | 3.76B | 3.23B | 3.98B | 7.11B | 10.07B | 6.23B |
| Investing Cash Flow | -2.49B | -3.23B | -3.73B | -2.50B | -5.70B | -2.87B |
| Financing Cash Flow | -2.20B | -1.31B | -3.06B | -2.59B | -2.51B | -3.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $18.68B | 14.73 | 11.18% | 1.63% | 8.49% | 9.68% | |
69 Neutral | $33.06B | 16.15 | 15.25% | 1.11% | 10.44% | 23.34% | |
66 Neutral | $51.49B | 13.28 | 11.16% | 1.34% | 5.73% | -10.36% | |
64 Neutral | $7.61B | 21.86 | 11.88% | 1.02% | 8.38% | 626.64% | |
63 Neutral | $42.94B | 17.20 | 5.87% | 1.03% | -1.31% | 149.74% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
51 Neutral | $23.19B | 14.72 | 1.19% | 3.22% | -5.70% | -9.39% |